Knockdown of p65 in A549 cells results in a decreased infection rate. by Janine J. Wilden (8849948)

Anti-TGFβ antibody decreased osteoclast numbers and <i>in vitro</i> osteoclastogenesis. by Swati Biswas (73661)

“…<p><b>Panel a:</b> Boxplot of number of TRAP positive osteoclasts per millimeter of bone surface in MBA-MB-231 tumor-bearing tibiae, showing significantly decreased osteoclasts upon 1D11 treatment, compared to 13C4. …”

Endoplasmic reticulum calcium decrease via RyR in response to HIV-1 Tat. by John P. Norman (269281)

Genistein decreases mouse liver lnfection by <i>P. berghei</i> ANKA sporozoites. by Margarida Cunha-Rodrigues (65513)

Hydroxychloroquine treatment decreases LAMP3-induced cell death <i>in vivo</i>. by Hiroyuki Nakamura (200082)

Effect of high-fructose (HFr) supplementation (500 μM) on markers of oxidative stress and HO-1 and SIRT1 gene expressions in hepatocytes treated with and without CoPP (5 μM) and Sn... by Komal Sodhi (540891)

Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Subjects:

Down-regulation of <i>T. gondii</i> P-gp correlates with decreased lipid synthesis. by Iveta Bottova (250537)

SARS-CoV-2 decreases excitatory synapses, while influenza A does not induce cell death in BCO. by Pinar Mesci (14053895)

Decreasing phagocytosis did not block NRF2 activation in <i>Lgy</i> infection. by Marta Reverte (10450927)

Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism-2 by John H Boyd (88940)

Decreased projections to LP in <i>Brn3b</i> mutants occur postnatally. by Hyoseo Lee (17419987)

“…(<b>H</b>) Quantification (1.00 ± 0.09 for control, 0.45 ± 0.03 for cKO); unpaired two-tailed Student’s <i>t</i> test (mean ± SEM; <i>p</i> < 0.0001 [****] at P4/P5; <i>p</i> = 0.0004 [***] at P8/P9; <i>p</i> = 0.0012 [**] at P12/P13). …”

Decreased sensitivity to apoptosis-related proteins in late passage <i>-/</i>- MEF cells. by Satoshi Miuma (117853)

Analysis of change in mature INPs, GMCs and neurons in the type II NB lineage on depletion of mitochondrial morphology proteins. by Dnyanesh Dubal (12085942)

Drp1^SD overexpression partially alleviates the differentiation defect seen in <i>notch</i> RNAi expressing type II NB lineages. by Dnyanesh Dubal (12085942)

Decreased levels of CIITA isoform III and isoform IV mRNA correlates with low levels of acetylation. by Agnieszka D. Truax (169208)

Cumulative effects and geographic distribution of mCHG-decreasing alleles. by Eriko Sasaki (501178)

“…<b>(D)</b> The number of recent transposon insertions [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1010345#pgen.1010345.ref022" target="_blank">22</a>] as a function of <i>NRPE1’</i> genotype and the number of mCHG-decreasing alleles. …”

Downregulation of Opa1 and Marf does affect type II NB numbers but affect differentiated cells in lineage. by Dnyanesh Dubal (12085942)

Drp1^SD overexpression in Opa1 or Marf depleted type II NBs rescues the reduced mitochondrial membrane potential. by Dnyanesh Dubal (12085942)

“…Scale bar- 10μm (A). Graph showing normalized TMRM intensities in +/+ (17 type II NBs, 8 brains), Drp1^SD (9,5), <i>opa1</i> RNAi (16,5), Drp1^SD;<i>opa1</i> RNAi 7,4), <i>marf</i> RNAi (11,5), Drp1^SD;<i>marf</i> RNAi (6,4) (B). …”